Heather B. Redman - 14 Jan 2022 Form 4 Insider Report for Brooklyn ImmunoTherapeutics, Inc. (ERNA)

Role
Director
Signature
/s/ Heather Redman
Issuer symbol
ERNA
Transactions as of
14 Jan 2022
Net transactions value
$0
Form type
4
Filing time
19 Jan 2022, 20:46:21 UTC
Previous filing
04 Jan 2022
Next filing
04 Apr 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ERNA Stock Option (right to buy) Award $0 +67,000 $0.000000 67,000 14 Jan 2022 Common Stock, par value $0.005 per share 67,000 $3.22 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests (subject to continued service) with respect to 22,336 shares of common stock on the first anniversary of the grant date and then in subsequent monthly installments of 1,861 shares of common stock through the three-year anniversary of the grant date.